-
Document de presse | 2014.06.01
Elucidating the pathogenic mechanism of meningococcal meningitis
Neisseria meningitidis, also called meningococcus, is a bacterium responsible for meningitis and septicemia[1]. Its most serious form, purpura fulminans, is often fatal. This bacterium, which is naturally present in humans in the nasopharynx, is pathogenic if it reaches the blood stream. Teams led by Dr. Sandrine Bourdoulous, CNRS senior researcher at the Institut Cochin (CNRS/INSERM/Université...
-
Fiche maladie | 2016.06.21
Zika
The Zika virus is a Flavivirus mainly transmitted by the bite of infected mosquitoes of the genus Aedes. It causes Zika virus disease.
-
Document de presse | 2017.07.20
Gene therapy: first results in children with Sanfilippo B syndrome
On July 13, 2017, the journal Lancet Neurology published the results of a gene therapy trial conducted in four children with Sanfilippo type B syndrome (also known as MPS IIIB). This trial is the achievement of a two-decade partnership with financial support of AFM-Téléthon and the cooperation of the charity "Vaincre les Maladies Lysosomales" (VML). After monitoring of the treated children for 30...
-
Document de presse | 2020.10.08
AIDS: Furthering Knowledge of Natural HIV Infection Control Mechanisms
A further step has just been taken in understanding the mechanisms that allow some individuals to control HIV infection without treatment.A research team led by Dr. Asier Sáez-Cirión (Institut Pasteur) and Dr. Bruno Vaslin (IDMIT[1], CEA-Inserm-Université Paris Saclay) observed for the first time that the antiviral activity of CD8+ T cells of "controller" macaques infected with the simian...
-
Document de presse | 2021.07.21
SARS-CoV-2 damages ciliated cells and inhibits mucociliary clearance in the airways
COVID-19 is a viral disease with respiratory symptoms that can induce fatal pneumonia. Understanding how SARS-CoV-2 spreads in the respiratory tract can help scientists identify the parameters controlling the severity of infection. Scientists from the Institut Pasteur, the CNRS and Inserm found that SARS-CoV-2 multiplies efficiently in the respiratory tract, and that it primarily targets ciliated...
-
News | 2023.01.30
Hepatitis B: towards better treatment for infected individuals in Africa
With 82 million people currently infected in Africa, the hepatitis B virus represents a major health threat. Early treatment can considerably reduce the risk of complications associated with the disease. In a recent analysis, scientists challenged the suitability of the diagnostic tests used in sub-Saharan Africa and called for more optimized treatment for local populations.
-
Document de presse | 2023.12.06
Plasmodium vivax malaria: infections may be largely underestimated in sub-Saharan Africa
Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University Hospital, in collaboration with King's College London, UK, the Institut Pasteur (Paris, France), the Institut Pasteur de Madagascar and the University of Addis Ababa, Ethiopia, have revealed how...
-
Document de presse | 2023.12.05
COVID-19: the persistence of SARS-CoV-2 in the lungs and the role of innate immunity
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut Pasteur specialized in HIV, in collaboration with a French public research institute, the Alternative Energies and Atomic Energy Commission (CEA), conducted a study on lung...
-
Événement | 2022.11.24
Colloquium for the centenary of Alphonse Laveran’s death
The French Defence Central Health Service ("Service de Santé des Armées" or SSA) pay a scientific and historical tribute to Alphonse Laveran, with a symposium on November 24, 2022 at the Val-de-Grâce School, to mark the centenary of his death. This event is organized with the scientific sponsorship of the Académie nationale de médecine (National Academy of Medicine) and the Institut Pasteur in...
-
News | 2026.02.12
Hepatitis B: two major breakthroughs raise hopes of eradicating chronic illness
Current treatments for hepatitis B do not cure the disease and often have to be taken for life. Two recent breakthroughs in the Institut Pasteur's research offer real hopes of progress for patients, at a time when 250 million people worldwide are living with chronic hepatitis B virus infection.